• In-depth local market knowlegde

    MORE
  • Seeking growth wherever it can be found 

    MORE
  • Undertaking responsible investment practices 

    MORE
  • Diversifing the expertise to benefit from new opportunities 

    MORE
  • Relying on experienced teams with complimentary backgrounds 

    MORE
  • Providing financial acumen and skill to our portfolio companies 

    MORE
  • Offering the best in class services to our investors 

    MORE

EXPERTISES

Since its inception in 1985, LBO France has become one of the leading Private Equity Managers in France. We have developed a multi-skilled platform focused on leveraged buyouts, venture capital, real estate and debt transactions.

  • Through the White Knight funds, LBO France invests as a majority shareholder in French champions.

    MORE
    Mid Cap Buyout
  • Through the Hexagone and Small Caps Opportunities funds, LBO France invests as the majority shareholder in dynamic French companies.

    MORE
    Small Cap Buyout
  • LBO France, through SISA fund in particular, supports the growth of innovative SMEs in Digital Health and Silver Economy.

    MORE
    Venture
  • With the White Stone and Lapillus funds, LBO France has two complementary real estate strategies: opportunistic value creation and medium-term returns.

    MORE
    Real Estate
  • The Senior Loan funds take advantage of opportunities in the private debt market with a focus on French €50-250m SMEs under LBO.

    MORE
    Debt

NEWS

  • 12
    June
    2018

    LBO France acquires a majority stake in My Media Group

    LBO France acquires a majority stake in My Media Group, the top independent French media buying agency and the sixth-largest overall.

  • 29
    May
    2018

    Voluntis successfully completes its IPO

    With €30m raised on the regulated market of Euronext in Paris, this is the 1st IPO in the digital therapeutics sector on a leading international stock exchange.

  • 30
    May
    2018

    Biomodex raises an additional $15m in Series A Funding

    With this funding, Biomodex, a medical device company that uses 3D printing technology to develop patient-specific synthetic organs for pre-operative planning, will develop new products in the interventional cardiology space and open a new manufacturing facility outside Boston, Massachusetts.

  • 23
    April
    2018

    LBO France strengthens its team

    The company has recruited three new members since the beginning of the year in two of the company's areas of expertise. Nicolas Manardo in the Small Cap team, Philippe Chambon and Sébastien Woynar in the Venture team.